메뉴 건너뛰기




Volumn 30, Issue 1, 2017, Pages 27-35

Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: Is the oral glucose tolerance test still the standard?

Author keywords

continuous glucose monitoring system; cystic fibrosis related diabetes; glucose metabolism; homeostasis model assessment index of insulin resistance; homeostasis model assessment index of cell function; intravenous glucose tolerance test; oral glucose tolerance test

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

EID: 85009799656     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2016-0184     Document Type: Article
Times cited : (31)

References (45)
  • 2
    • 84878350788 scopus 로고    scopus 로고
    • Update on cystic fibrosis-related diabetes
    • Kelly A, Moran A. Update on cystic fibrosis-related diabetes. J Cyst Fibros 2013;12:318-31.
    • (2013) J Cyst Fibros , vol.12 , pp. 318-331
    • Kelly, A.1    Moran, A.2
  • 3
    • 84867166324 scopus 로고    scopus 로고
    • Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets
    • Olivier AK, Yi Y, Sun X, Sui H, Liang B, et al. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest 2012;122:3755-68.
    • (2012) J Clin Invest , vol.122 , pp. 3755-3768
    • Olivier, A.K.1    Yi, Y.2    Sun, X.3    Sui, H.4    Liang, B.5
  • 4
    • 84904490730 scopus 로고    scopus 로고
    • Glucoseinduced electrical activities and insulin secretion in pancreatic islet β-cells are modulated by CFTR
    • Guo JH, Chen H, Ruan YC, Zhang XL, Zhang XH, et al. Glucoseinduced electrical activities and insulin secretion in pancreatic islet β-cells are modulated by CFTR. Nat Commun 2014;5:4420.
    • (2014) Nat Commun , vol.5 , pp. 4420
    • Guo, J.H.1    Chen, H.2    Ruan, Y.C.3    Zhang, X.L.4    Zhang, X.H.5
  • 6
    • 0033825741 scopus 로고    scopus 로고
    • Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline
    • Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000;162(3 Pt 1):891-5.
    • (2000) Am J Respir Crit Care Med , vol.162 , Issue.3 , pp. 891-895
    • Milla, C.E.1    Warwick, W.J.2    Moran, A.3
  • 7
    • 80051982707 scopus 로고    scopus 로고
    • Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: A 3-year prospective study
    • Kolouskova S, Zemkova D, Bartosova J, Skalicka V, Sumnik Z, et al. Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study. J Pediatr Endocrinol Metab 2011;24:449-54.
    • (2011) J Pediatr Endocrinol Metab , vol.24 , pp. 449-454
    • Kolouskova, S.1    Zemkova, D.2    Bartosova, J.3    Skalicka, V.4    Sumnik, Z.5
  • 8
    • 78651369030 scopus 로고    scopus 로고
    • Clinical care guidelines for cystic fibrosis-related diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society
    • Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;33:2697-708.
    • (2010) Diabetes Care , vol.33 , pp. 2697-2708
    • Moran, A.1    Brunzell, C.2    Cohen, R.C.3    Katz, M.4    Marshall, B.C.5
  • 9
    • 84906826756 scopus 로고    scopus 로고
    • International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosisrelated diabetes in children and adolescents
    • Moran A, Pillay K, Becker DJ, Acerini CL, International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosisrelated diabetes in children and adolescents. Pediatr Diabetes 2014;15(Suppl 20):65-76.
    • (2014) Pediatr Diabetes , vol.15 , pp. 65-76
    • Moran, A.1    Pillay, K.2    Becker, D.J.3    Acerini, C.L.4
  • 10
    • 3142693578 scopus 로고    scopus 로고
    • Conventional measures underestimate glycaemia in cystic fibrosis patients
    • Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004;21:691-6.
    • (2004) Diabet Med , vol.21 , pp. 691-696
    • Dobson, L.1    Sheldon, C.D.2    Hattersley, A.T.3
  • 11
    • 79951695879 scopus 로고    scopus 로고
    • Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis
    • Brodsky J, Dougherty S, Makani R, Rubenstein RC, Kelly A. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis. Diabetes Care 2011;34:292-5.
    • (2011) Diabetes Care , vol.34 , pp. 292-295
    • Brodsky, J.1    Dougherty, S.2    Makani, R.3    Rubenstein, R.C.4    Kelly, A.5
  • 13
    • 84902306654 scopus 로고    scopus 로고
    • Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients
    • Leclercq A, Gauthier B, Rosner V, Weiss L, Moreau F, et al. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients. J Cyst Fibros 2014;13:478-84.
    • (2014) J Cyst Fibros , vol.13 , pp. 478-484
    • Leclercq, A.1    Gauthier, B.2    Rosner, V.3    Weiss, L.4    Moreau, F.5
  • 14
    • 85026278044 scopus 로고    scopus 로고
    • 178 Glucose tolerance in cystic fibrosis patients over a 3-year period (DIAMUCO study)
    • Bourdy S, Rabilloud M, Touzet S, Roche S, Drai J, et al. 178 Glucose tolerance in cystic fibrosis patients over a 3-year period (DIAMUCO study). J Cyst Fibros 2015;14:S103.
    • (2015) J Cyst Fibros , vol.14 , pp. S103
    • Bourdy, S.1    Rabilloud, M.2    Touzet, S.3    Roche, S.4    Drai, J.5
  • 15
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5
  • 16
    • 84875911756 scopus 로고    scopus 로고
    • Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy
    • Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J 2013;60:283-90.
    • (2013) Endocr J , vol.60 , pp. 283-290
    • Okita, K.1    Iwahashi, H.2    Kozawa, J.3    Okauchi, Y.4    Funahashi, T.5
  • 17
    • 3042740809 scopus 로고    scopus 로고
    • Population-based incidence rates and risk factors for type 2 diabetes in white individuals: The Bruneck study
    • Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 2004;53:1782-9.
    • (2004) Diabetes , vol.53 , pp. 1782-1789
    • Bonora, E.1    Kiechl, S.2    Willeit, J.3    Oberhollenzer, F.4    Egger, G.5
  • 18
    • 0031851293 scopus 로고    scopus 로고
    • Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
    • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
    • (1998) Diabet Med , vol.15 , pp. 539-553
    • Alberti, K.G.1    Zimmet, P.Z.2
  • 19
    • 33845493476 scopus 로고    scopus 로고
    • Prevalence and determinants of insulin resistance among U.S. Adolescents: A population-based study
    • Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006; 29:2427-32.
    • (2006) Diabetes Care , vol.29 , pp. 2427-2432
    • Lee, J.M.1    Okumura, M.J.2    Davis, M.M.3    Herman, W.H.4    Gurney, J.G.5
  • 21
    • 20544455541 scopus 로고    scopus 로고
    • Use of waist circumference to predict insulin resistance: Retrospective study
    • Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, et al. Use of waist circumference to predict insulin resistance: retrospective study. Br Med J 2005;330:1363-4.
    • (2005) Br Med J , vol.330 , pp. 1363-1364
    • Wahrenberg, H.1    Hertel, K.2    Leijonhufvud, B.M.3    Persson, L.G.4    Toft, E.5
  • 22
    • 23244445787 scopus 로고    scopus 로고
    • Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents
    • Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-3.
    • (2005) Pediatrics , vol.115 , pp. e500-e503
    • Keskin, M.1    Kurtoglu, S.2    Kendirci, M.3    Atabek, M.E.4    Yazici, C.5
  • 24
    • 40749157441 scopus 로고    scopus 로고
    • Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis
    • Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008;152:540-5.
    • (2008) J Pediatr , vol.152 , pp. 540-545
    • Bismuth, E.1    Laborde, K.2    Taupin, P.3    Velho, G.4    Ribault, V.5
  • 25
    • 48349134989 scopus 로고    scopus 로고
    • Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance
    • Moreau F, Weiller MA, Rosner V, Weiss L, Hasselmann M, et al. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 2008;40:502-6.
    • (2008) Horm Metab Res , vol.40 , pp. 502-506
    • Moreau, F.1    Ma, W.2    Rosner, V.3    Weiss, L.4    Hasselmann, M.5
  • 26
    • 77950309283 scopus 로고    scopus 로고
    • Abnormal glucose tolerance in children with cystic fibrosis: The predictive role of continuous glucose monitoring system
    • Schiaffini R, Brufani C, Russo B, Fintini D, Migliaccio A, et al. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. Eur J Endocrinol 2010;162:705-10.
    • (2010) Eur J Endocrinol , vol.162 , pp. 705-710
    • Schiaffini, R.1    Brufani, C.2    Russo, B.3    Fintini, D.4    Migliaccio, A.5
  • 27
    • 84890440133 scopus 로고    scopus 로고
    • Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test
    • Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. J Cyst Fibros 2014;13:80-5.
    • (2014) J Cyst Fibros , vol.13 , pp. 80-85
    • Schmid, K.1    Fink, K.2    Holl, R.W.3    Hebestreit, H.4    Ballmann, M.5
  • 28
    • 84937908944 scopus 로고    scopus 로고
    • The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis
    • Coriati A, Ziai S, Lavoie A, Berthiaume Y, Rabasa-Lhoret R. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis. Acta Diabetol 2016;53:359-66.
    • (2016) Acta Diabetol , vol.53 , pp. 359-366
    • Coriati, A.1    Ziai, S.2    Lavoie, A.3    Berthiaume, Y.4    Rabasa-Lhoret, R.5
  • 29
    • 84941736537 scopus 로고    scopus 로고
    • Elevation of one hour plasma glucose during oral glucose tolerance testing: 1-hour plasma glucose and cystic fibrosis
    • Sheikh S, Putt ME, Forde KA, Rubenstein RC, Kelly A. Elevation of one hour plasma glucose during oral glucose tolerance testing: 1-hour plasma glucose and cystic fibrosis. Pediatr Pulmonol 2015;50:963-9.
    • (2015) Pediatr Pulmonol , vol.50 , pp. 963-969
    • Sheikh, S.1    Putt, M.E.2    Forde, K.A.3    Rubenstein, R.C.4    Kelly, A.5
  • 30
    • 84939142834 scopus 로고    scopus 로고
    • Age-and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients
    • Battezzati A, Bedogni G, Zazzeron L, Mari A, Battezzati PM, et al. Age-and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients. J Clin Endocrinol Metab 2015;100:2963-71.
    • (2015) J Clin Endocrinol Metab , vol.100 , pp. 2963-2971
    • Battezzati, A.1    Bedogni, G.2    Zazzeron, L.3    Mari, A.4    Battezzati, P.M.5
  • 31
    • 0042168870 scopus 로고    scopus 로고
    • Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis
    • Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003;26:1940-1.
    • (2003) Diabetes Care , vol.26 , pp. 1940-1941
    • Dobson, L.1    Sheldon, C.D.2    Hattersley, A.T.3
  • 32
    • 66549100244 scopus 로고    scopus 로고
    • Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: A prospective cohort study
    • ORiordan SMP, Hindmarsh P, Hill NR, Matthews DR, George S, et al. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study. Diabetes Care 2009;32:1020-2.
    • (2009) Diabetes Care , vol.32 , pp. 1020-1022
    • Smp, O.1    Hindmarsh, P.2    Hill, N.R.3    Matthews, D.R.4    George, S.5
  • 33
  • 34
  • 35
    • 36148980089 scopus 로고    scopus 로고
    • Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes
    • Elder DA, Wooldridge JL, Dolan LM, DAlessio DA. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. J Pediatr 2007;151:653-8.
    • (2007) J Pediatr , vol.151 , pp. 653-658
    • Elder, D.A.1    Wooldridge, J.L.2    Dolan, L.M.3    Dalessio, D.A.4
  • 36
    • 79955732470 scopus 로고    scopus 로고
    • Kinetics of insulin secretion and glucose intolerance in adult patients with cystic fibrosis
    • Anzeneder L, Kircher F, Feghelm N, Fischer R, Seissler J. Kinetics of insulin secretion and glucose intolerance in adult patients with cystic fibrosis. Horm Metab Res 2011;43:355-60.
    • (2011) Horm Metab Res , vol.43 , pp. 355-360
    • Anzeneder, L.1    Kircher, F.2    Feghelm, N.3    Fischer, R.4    Seissler, J.5
  • 37
    • 84878252092 scopus 로고    scopus 로고
    • Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes
    • Sunni M, Bellin MD, Moran A. Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes. Pediatr Diabetes 2013;14:295-8.
    • (2013) Pediatr Diabetes , vol.14 , pp. 295-298
    • Sunni, M.1    Bellin, M.D.2    Moran, A.3
  • 38
    • 84921607278 scopus 로고    scopus 로고
    • Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis
    • Cano Megias M, Gonzalez Albarran O, Guisado Vasco P, Lamas Ferreiro A, Maiz Carro L. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis. Endocrinol Nutr 2015;62:91-9.
    • (2015) Endocrinol Nutr , vol.62 , pp. 91-99
    • Cano Megias, M.1    Gonzalez Albarran, O.2    Guisado Vasco, P.3    Lamas Ferreiro, A.4    Maiz Carro, L.5
  • 39
    • 85009735355 scopus 로고    scopus 로고
    • Glucose tolerance in infants and young children with CF
    • Ode KL. Glucose tolerance in infants and young children with CF. Pediatr Pulmonol 2014;49: S216-456.
    • (2014) Pediatr Pulmonol , vol.49 , pp. S216-S456
    • Ode, K.L.1
  • 40
    • 84962179912 scopus 로고    scopus 로고
    • The F508 mutation in the cystic fibrosis transmembrane conductance regulator is associated with progressive insulin resistance and decreased functional beta-cell mass in mice
    • Fontes G, Ghislain J, Benterki I, Zarrouki B, Trudel D, et al. The F508 mutation in the cystic fibrosis transmembrane conductance regulator is associated with progressive insulin resistance and decreased functional beta-cell mass in mice. Diabetes 2015;64:4112-22.
    • (2015) Diabetes , vol.64 , pp. 4112-4122
    • Fontes, G.1    Ghislain, J.2    Benterki, I.3    Zarrouki, B.4    Trudel, D.5
  • 41
    • 84862843727 scopus 로고    scopus 로고
    • Insulin production and resistance in cystic fibrosis: Effect of age, disease activity, and genotype
    • Street ME, Spaggiari C, Ziveri MA, Rossi M, Volta C, et al. Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype. J Endocrinol Invest 2012; 35:246-53.
    • (2012) J Endocrinol Invest , vol.35 , pp. 246-253
    • Street, M.E.1    Spaggiari, C.2    Ma, Z.3    Rossi, M.4    Volta, C.5
  • 42
    • 84937814992 scopus 로고    scopus 로고
    • Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: How, when, why
    • Franzese A, Mozzillo E, Fattorusso V, Raia V, Valerio G. Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why. Acta Diabetol 2015;52:633-8.
    • (2015) Acta Diabetol , vol.52 , pp. 633-638
    • Franzese, A.1    Mozzillo, E.2    Fattorusso, V.3    Raia, V.4    Valerio, G.5
  • 43
    • 0028978492 scopus 로고
    • Glucose tolerance in patients with cystic fibrosis: Five year prospective study
    • Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. Br Med J 1995;311:655-9.
    • (1995) Br Med J , vol.311 , pp. 655-659
    • Lanng, S.1    Hansen, A.2    Thorsteinsson, B.3    Nerup, J.4    Koch, C.5
  • 44
    • 57049188814 scopus 로고    scopus 로고
    • No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes
    • Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, et al. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab 2008;34:568-73.
    • (2008) Diabetes Metab , vol.34 , pp. 568-573
    • Godbout, A.1    Hammana, I.2    Potvin, S.3    Mainville, D.4    Rakel, A.5
  • 45
    • 84958555125 scopus 로고    scopus 로고
    • Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes
    • Boudreau V, Coriati A, Desjardins K, Rabasa-Lhoret R. Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes. J Cyst Fibros 2016;15:258-60.
    • (2016) J Cyst Fibros , vol.15 , pp. 258-260
    • Boudreau, V.1    Coriati, A.2    Desjardins, K.3    Rabasa-Lhoret, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.